aromasil has been researched along with formestane in 23 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 8 (34.78) | 18.2507 |
2000's | 9 (39.13) | 29.6817 |
2010's | 5 (21.74) | 24.3611 |
2020's | 1 (4.35) | 2.80 |
Authors | Studies |
---|---|
An, J; Davies, HM; Egbuta, C; Ghosh, D; Griswold, J; Hubbell, S; Jiang, W; Lo, J; Morton, D; Valette, D; Xi, J | 1 |
Barmade, MA; Murumkar, PR; Tamboli, RS; Yadav, MR | 1 |
Alcaro, S; Amaral, C; Carvalho, RA; Correia-da-Silva, G; Costa, G; Costa, SC; Roleira, FM; Tavares-da-Silva, EJ; Teixeira, NA; Varela, CL | 1 |
Alcaro, S; Amaral, C; Correia-da-Silva, G; Costa, G; Costa, SC; Moraca, F; Roleira, FMF; Tavares da Silva, EJ; Teixeira, NAA; Varela, C | 1 |
Chen, JZ; Khan, MZI; Nazli, A; Uzair, M | 1 |
Coombes, RC; di Salle, E; Evans, TR; Giudici, D; Lassus, M; Ornati, G | 1 |
Briatico, G; D'Alessio, R; Di Salle, E; Giudici, D; Lombardi, P; Ornati, G; Villa, V | 1 |
Briatico, G; di Salle, E; Giudici, D; Ornati, G | 1 |
Lønning, PE | 1 |
Anker, GB; Johannessen, DC; Lien, EA; Lonning, PE; Refsum, H; Ueland, PM | 1 |
Blijham, GH; de Jong, PC | 1 |
Bonneterre, J; Feutrie, ML | 1 |
Harvey, HA; Santen, RJ | 1 |
Bajetta, E; Bichisao, E; Pozzi, P; Toffolatti, L; Zilembo, N | 1 |
Auvray, P; Bichat, F; Genne, P | 1 |
de Crémoux, P | 1 |
Kerbrat, P; Lefeuvre, C | 1 |
Buzdar, A; Howell, A | 1 |
Lombardi, P | 1 |
Delozier, T; Khayat, D; Spano, JP | 1 |
Chen, S; Wang, X | 1 |
Dutta, U; Pant, K | 1 |
Csákvári, E; Gyenes, A; Hoyk, Z; Kóti, J; Paragi, G; Párducz, A; Pfoh, R; Rühl, S; Szájli, A; Wölfling, J | 1 |
15 review(s) available for aromasil and formestane
Article | Year |
---|---|
Developing steroidal aromatase inhibitors-an effective armament to win the battle against breast cancer.
Topics: Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Female; Humans; Models, Molecular; Molecular Structure | 2015 |
An overview on Estrogen receptors signaling and its ligands in breast cancer.
Topics: Breast Neoplasms; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Ligands; Male; Receptors, Estrogen | 2022 |
Exemestane (FCE 24304), a new steroidal aromatase inhibitor.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Humans; Lyases; Receptors, Steroid | 1992 |
Pharmacological profiles of exemestane and formestane, steroidal aromatase inhibitors used for treatment of postmenopausal breast cancer.
Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Neoplasms, Hormone-Dependent; Postmenopause | 1998 |
New aromatase inhibitors for the treatment of advanced breast cancer in postmenopausal women.
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase III as Topic; Female; Humans; Letrozole; Megestrol Acetate; Nitriles; Postmenopause; Triazoles | 1999 |
[Aromatase inhibitors].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Estrogen Antagonists; Estrone; Female; Humans; Letrozole; Nitriles; Triazoles | 1999 |
Use of aromatase inhibitors in breast carcinoma.
Topics: Adult; Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Drug Design; Drug Interactions; Drug Resistance, Neoplasm; Enzyme Inhibitors; Estrogens; Female; Humans; Letrozole; Middle Aged; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Premenopause; Tamoxifen; Triazoles | 1999 |
Steroidal aromatase inhibitors in elderly patients.
Topics: Aged; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Preclinical evaluation of aromatase inhibitors antitumor activity].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Animals; Antineoplastic Agents, Hormonal; Aromatase; Aromatase Inhibitors; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Models, Animal; Nitriles; Rats; Structure-Activity Relationship; Triazoles | 2000 |
[Aromatase inhibitors: pharmacological aspects].
Topics: Aminoglutethimide; Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Enzyme Inhibitors; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2000 |
[Aromatase inhibitors: a review of clinical trials].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Enzyme Inhibitors; Female; Humans; Letrozole; Nitriles; Randomized Controlled Trials as Topic; Triazoles | 2000 |
Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.
Topics: Anastrozole; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Fadrozole; Female; Headache; Humans; Letrozole; Nausea; Nitriles; Treatment Outcome; Triazoles; Vomiting | 2001 |
Exemestane, a new steroidal aromatase inhibitor of clinical relevance.
Topics: Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Enzyme Inhibitors; Estrogen Receptor Modulators; Estrogens; Female; Humans; Neoplasms, Hormone-Dependent | 2002 |
[Aromatase inhibitors in adjuvant setting in breast cancer].
Topics: Anastrozole; Androstadienes; Androstenedione; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Letrozole; Menopause; Nitriles; Triazoles | 2004 |
Aromatase inhibitors: past, present and future in breast cancer therapy.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Clinical Trials as Topic; Fadrozole; Female; Humans; Letrozole; Nitriles; Triazoles | 2008 |
1 trial(s) available for aromasil and formestane
Article | Year |
---|---|
Exemestane (FCE 24304), a new steroidal aromatase inhibitor.
Topics: 5-alpha Reductase Inhibitors; Androgens; Androstadienes; Androstenedione; Animals; Antineoplastic Agents; Aromatase Inhibitors; Humans; Lyases; Receptors, Steroid | 1992 |
8 other study(ies) available for aromasil and formestane
Article | Year |
---|---|
Novel aromatase inhibitors by structure-guided design.
Topics: Androstadienes; Antineoplastic Agents; Aromatase Inhibitors; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Molecular Docking Simulation; Molecular Structure; Placenta; Pregnancy; Protein Binding; Stereoisomerism; Structure-Activity Relationship | 2012 |
Exploring new chemical functionalities to improve aromatase inhibition of steroids.
Topics: Androstanes; Androstenedione; Aromatase; Aromatase Inhibitors; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Molecular Docking Simulation; Steroids; Structure-Activity Relationship | 2016 |
C-6α- vs C-7α-Substituted Steroidal Aromatase Inhibitors: Which Is Better? Synthesis, Biochemical Evaluation, Docking Studies, and Structure-Activity Relationships.
Topics: Aromatase Inhibitors; Humans; Molecular Docking Simulation; Steroids; Structure-Activity Relationship | 2019 |
4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
Topics: Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Male; Pregnancy; Rats; Rats, Inbred Strains | 1990 |
Novel irreversible aromatase inhibitors.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Animals; Aromatase Inhibitors; Female; Gonadotropins, Equine; Humans; In Vitro Techniques; Kinetics; Microsomes; Ovary; Pargyline; Placenta; Rats; Rats, Inbred Strains | 1990 |
Influence of aromatase inhibitors on plasma total homocysteine in postmenopausal breast cancer patients.
Topics: Aminoglutethimide; Androstadienes; Androstenedione; Aromatase Inhibitors; Breast Neoplasms; Creatinine; Enzyme Inhibitors; Estrogen Antagonists; Homocysteine; Humans; Postmenopause; Vitamins | 1999 |
Aromatase destabilizer: novel action of exemestane, a food and drug administration-approved aromatase inhibitor.
Topics: Androstadienes; Androstenedione; Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Stability; Female; Humans; Proteasome Endopeptidase Complex | 2006 |
Computer-aided structure analysis of an epimerized dehydroepiandrosterone derivative and its biological effect in a model of reactive gliosis.
Topics: Androstadienes; Androstenedione; Animals; Aromatase; Aromatase Inhibitors; Crystallography, X-Ray; Dehydroepiandrosterone; Glial Fibrillary Acidic Protein; Gliosis; Male; Molecular Sequence Data; Molecular Structure; Rats; Rats, Wistar | 2010 |